文献速递免疫规划传染病防控与疫情报告

2023年9月22日SPEAC网络研讨会报告:感音神经性听力损失、拉沙病毒病与疫苗

Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.
PubMed 文献 · Vaccine · 2024-11-22

拉沙病毒在西非多国流行并可致病毒性出血热,尼日利亚CDC报告2024年疫情至8月11日累计疑似病例7767例、确诊病例971例、死亡166例。拉沙病毒感染后最高30%患者可出现感音神经性听力损失(SNHL),尽管临床试验尚未显示拉沙疫苗免疫应答会引发SNHL,CEPI与SPEAC于2023年9月22日召开网络研讨会综述动物与人体证据并讨论未来试验听力评估。

要点

  • 拉沙病毒病可致感音神经性听力损失,最高达30%患者受影响。
  • 拉沙疫苗是否经免疫应答引发SNHL尚待临床试验评估。
  • 研讨会建议在儿童与成人拉沙疫苗扩大试验中纳入听力评估。

核心结论

  • 拉沙病毒感染可致最高30%患者感音神经性听力损失,但临床试验迄今未显示拉沙疫苗免疫接种会引发SNHL。
  • 研讨会综述动物与人体证据,为未来拉沙疫苗候选在儿童和成人中扩大试验的听力评估提供考量。

研究设计与样本

  • CEPI与Brighton Collaboration安全平台SPEAC于2023年9月22日召开三小时网络研讨会,综述动物研究与人体临床试验证据。

主要发现

  • 尼日利亚CDC报告2024年拉沙热疫情至8月11日累计疑似病例7767例、确诊病例971例、死亡166例,波及28个州。
  • 拉沙病毒感染后最高30%患者出现感音神经性听力损失,但临床试验迄今未显示疫苗免疫接种引发SNHL。

临床怎么用

  • 作者建议在儿童与成人拉沙疫苗候选的扩大人体试验中开展听力评估以助风险评估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lassa virus (LASV) belongs to the Arenavirus family. LASV is endemic in several West Africa countries and causes viral hemorrhagic fevers. The Nigeria CDC has reported that an outbreak in 2024 in 28 states has resulted in 7767 suspected cases of Lassa fever, 971 confirmed cases and 166 confirmed deaths up to 11 August. Since infection with LASV can result in sensorineural hearing loss (SNHL) in up to 30% of patients, there are questions about whether triggering the immune response by immunization with LASV vaccines could potentially cause SNHL, although this has not been shown in clinical trials to date. To address this issue, the Coalition for Epidemic Preparedness Innovations (CEPI) and the Brighton Collaboration (BC) Safety Platform for Emergency vACcines (SPEAC) convened a three-hour webinar on 22 September 2023 to review what is known from both animal studies and human clinical trials and how hearing assessments in future clinical trials can help to assess the risk. This report summarizes the evidence presented and provides considerations for hearing assessment in expanded human trials of LASV vaccine candidates in children and adults.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Reed NS, Brewer CC, Akintunde G, et al. Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines. Vaccine. 2024. PMID: 39579650. doi:10.1016/j.vaccine.2024.126525

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。